Vasamed, Inc.
VSMD · OTC
12/31/2005 | 12/31/2004 | 12/31/2003 | 12/31/2002 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $2 | $2 |
| % Growth | 29.7% | -49.7% | 34.9% | – |
| Cost of Goods Sold | $1 | $1 | $2 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $1 |
| % Margin | -5% | -29.8% | 14.9% | 73.2% |
| R&D Expenses | $2 | $4 | $1 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $6 | $3 | $3 |
| Operating Income | $5 | $6 | $2 | $2 |
| % Margin | 342.1% | 588.8% | 107.7% | 119.5% |
| Other Income/Exp. Net | -$5 | -$3 | -$2 | -$2 |
| Pre-Tax Income | $5 | $6 | $2 | $2 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | -$5 | -$6 | -$2 | -$2 |
| % Margin | -352.6% | -600.7% | -107.4% | -117.6% |
| EPS | -1.31 | -1.85 | -0.71 | -0.67 |
| % Growth | 29.2% | -160.6% | -6% | – |
| EPS Diluted | -1.31 | -1.85 | -0.71 | -0.67 |
| Weighted Avg Shares Out | 4 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 4 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$6 | -$2 | -$2 |
| % Margin | -330% | -568.1% | -103.4% | -110.3% |